相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Poly(ethylene glycol)-block-poly(D,L-lactic acid) micelles containing oligo (lactic acid)8-paclitaxel prodrug: In Vivo conversion and antitumor efficacy
Yu Tong Tam et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Stereocomplex Prodrugs of Oligo(lactic acid)(n)-Gemcitabine in Polyethylene glycol)biock-poly(D,L-lactic acid) Micelles for Improved Physical Stability and Enhanced Antitumor Efficacy
Yu Tong Tam et al.
ACS NANO (2018)
Block Copolymer Micelles in Nanomedicine Applications
Horacio Cabral et al.
CHEMICAL REVIEWS (2018)
Overcoming the Road Blocks: Advancement of Block Copolymer Micelles for Cancer Therapy in the Clinic
Loujin Houdaihed et al.
MOLECULAR PHARMACEUTICS (2017)
Synthesis and evaluation of an injectable everolimus prodrug
Haibo Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery
Hyunah Cho et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity
Yu Tong Tam et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Polymeric micelle nanocarriers in cancer research
Dae Hwan Shin et al.
FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING (2016)
Toward rapamycin analog (rapalog)-based precision cancer therapy
Ling-hua Meng et al.
ACTA PHARMACOLOGICA SINICA (2015)
Everolimus and Temsirolimus Are Not the Same Second-Line in Metastatic Renal Cell Carcinoma. A Systematic Review and Meta-Analysis of Literature Data
Roberto Iacovelli et al.
CLINICAL GENITOURINARY CANCER (2015)
A Novel Rapamycin-Polymer Conjugate Based on a New Poly(Ethylene Glycol) Multiblock Copolymer
Wanyi Tai et al.
PHARMACEUTICAL RESEARCH (2014)
Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs
Wei Xu et al.
JOURNAL OF DRUG DELIVERY (2013)
Polymeric micelle stability
Shawn C. Owen et al.
NANO TODAY (2012)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Common toxicities of mammalian target of rapamycin inhibitors
Scott A. Soefje et al.
TARGETED ONCOLOGY (2011)
mToR signaling and drug development in cancer
Janet Dancey
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Temsirolimus, an inhibitor of mammalian target of rapamycin
Brian I. Rini
CLINICAL CANCER RESEARCH (2008)
Molecularly defined (L)-lactic acid oligomers and polymers: Synthesis and characterization
Kenichi Takizawa et al.
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY (2008)
Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin
Jaime A. Yanez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Rapamycin: Something old, something new, sometimes borrowed and now renewed
C. M. Hartford et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Synthesis of poly(L-lactide) and polyglycolide by ring-opening polymerization
Sachiko Kaihara et al.
NATURE PROTOCOLS (2007)
In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(ε-caprolactone) micelles
ML Forrest et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Enzymes involved in the bioconversion of ester-based prodrugs
Bianca M. Liederer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Interfaces and the driving force of hydrophobic assembly
D Chandler
NATURE (2005)
Hydrolytic degradation of oligo(lactic acid): a kinetic and mechanistic study
CF van Nostrum et al.
POLYMER (2004)
Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer
E Raymond et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles
T Riley et al.
LANGMUIR (2001)
分享论文
